[go: up one dir, main page]

FR2546166B1 - Enantiomeres du erythro (benzyl-4 piperidino)-2 (hydroxy-4 ou benzyloxy-4 phenyl)-1 propanol, leur preparation et leur application en therapeutique - Google Patents

Enantiomeres du erythro (benzyl-4 piperidino)-2 (hydroxy-4 ou benzyloxy-4 phenyl)-1 propanol, leur preparation et leur application en therapeutique

Info

Publication number
FR2546166B1
FR2546166B1 FR8308290A FR8308290A FR2546166B1 FR 2546166 B1 FR2546166 B1 FR 2546166B1 FR 8308290 A FR8308290 A FR 8308290A FR 8308290 A FR8308290 A FR 8308290A FR 2546166 B1 FR2546166 B1 FR 2546166B1
Authority
FR
France
Prior art keywords
erythro
piperidino
benzyloxy
enantiomers
propanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8308290A
Other languages
English (en)
Other versions
FR2546166A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to FR8308290A priority Critical patent/FR2546166B1/fr
Publication of FR2546166A1 publication Critical patent/FR2546166A1/fr
Application granted granted Critical
Publication of FR2546166B1 publication Critical patent/FR2546166B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
FR8308290A 1983-05-19 1983-05-19 Enantiomeres du erythro (benzyl-4 piperidino)-2 (hydroxy-4 ou benzyloxy-4 phenyl)-1 propanol, leur preparation et leur application en therapeutique Expired FR2546166B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR8308290A FR2546166B1 (fr) 1983-05-19 1983-05-19 Enantiomeres du erythro (benzyl-4 piperidino)-2 (hydroxy-4 ou benzyloxy-4 phenyl)-1 propanol, leur preparation et leur application en therapeutique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8308290A FR2546166B1 (fr) 1983-05-19 1983-05-19 Enantiomeres du erythro (benzyl-4 piperidino)-2 (hydroxy-4 ou benzyloxy-4 phenyl)-1 propanol, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
FR2546166A1 FR2546166A1 (fr) 1984-11-23
FR2546166B1 true FR2546166B1 (fr) 1985-10-25

Family

ID=9288990

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8308290A Expired FR2546166B1 (fr) 1983-05-19 1983-05-19 Enantiomeres du erythro (benzyl-4 piperidino)-2 (hydroxy-4 ou benzyloxy-4 phenyl)-1 propanol, leur preparation et leur application en therapeutique

Country Status (1)

Country Link
FR (1) FR2546166B1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987000433A1 (fr) * 1985-07-24 1987-01-29 Grelan Pharmaceutical Co., Ltd. Agent ameliorant la circulation
US5272160A (en) * 1989-05-17 1993-12-21 Pfizer Inc 2-piperidino-1-alkanol derivatives as antiischemic agents
WO1990014087A1 (fr) * 1989-05-17 1990-11-29 Pfizer Inc. Derives de 2-piperidino-1-alcanol en tant qu'agents antiischemiques
FR2654341B1 (fr) * 1989-11-14 1994-09-23 Synthelabo Utilisation d'ifenprodil et de ses derives pour la fabrication de medicaments antipsychotiques.
BR9106432A (pt) * 1990-05-10 1993-05-04 Pfizer Indolona neuroprotetora e derivados correlatos
BR9206272A (pt) * 1991-07-17 1995-04-11 Pfizer Derivados de 2-(4-hidroxipiperidino)-1-alcanol, como agentes anti-isquêmicos.
US5527912A (en) * 1991-10-23 1996-06-18 Pfizer Inc. Intermediates for 2-piperidino-1-alkanol derivatives
US5710168A (en) * 1991-10-23 1998-01-20 Pfizer Inc. 2-piperidino-1-alkanol derivatives as neuroprotective agents
US6255322B1 (en) 1992-06-19 2001-07-03 Pfizer Inc. 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents
US5436255A (en) * 1992-07-23 1995-07-25 Pfizer Inc. Method of treating diseases susceptable to treatment by blocking NMDA-receptors
AU669206B2 (en) * 1992-10-30 1996-05-30 Pfizer Inc. Neuroprotective 3,4-dihydro-2(1H)-quinolone compounds
US5498610A (en) * 1992-11-06 1996-03-12 Pfizer Inc. Neuroprotective indolone and related derivatives
BR9408506A (pt) * 1994-01-31 1997-08-05 Pfizer Compostos neuroprotetores
US6046213A (en) * 1994-08-18 2000-04-04 Pfizer Inc. Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydroxyphenyl)-2-(piperidinyl-1)-alkanol derivatives
CA3236307A1 (fr) * 2021-10-25 2023-05-04 Christopher BRYAN Sels d'ifenprodil et leurs utilisations therapeutiques

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1142030A (en) * 1966-06-14 1969-02-05 Ciba Ltd Optically active substituted piperidine compounds
FR2503705A1 (fr) * 1981-04-14 1982-10-15 Synthelabo Derives de phenethanolamine, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
FR2546166A1 (fr) 1984-11-23

Similar Documents

Publication Publication Date Title
FR2546166B1 (fr) Enantiomeres du erythro (benzyl-4 piperidino)-2 (hydroxy-4 ou benzyloxy-4 phenyl)-1 propanol, leur preparation et leur application en therapeutique
FR2579596B1 (fr) (imidazolyl-4) piperidines, leur preparation et leur application en therapeutique
IS3711A7 (is) Bætt aðferð við tilurð omeprazole
MA19845A1 (fr) Nouvelles piperidinamines et leur preparation
FR2589359B1 (fr) Canule aortique
FI834062A0 (fi) Med vatten uppskummat och med silan tvaerbundet polyolefinskum och foerfarande foer framstaellning detta
FR2587029B1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique
IT1152924B (it) Sacchetto medico e metodo per la fabbricazione dello stesso
FR2659323B1 (fr) Derives de 4-(aminomethyl) piperidine, leur preparation et leur application en therapeutique.
FR2618149B1 (fr) Derives de n-aminoalkyl n-phenyl arylamides, leur preparation et leur application en therapeutique
FR2568774B2 (fr) Medicaments favorisant les proprietes d'ecoulement du sang et leur utilisation en therapeutique
FR2580281B1 (fr) Derives du nitrofuranne, leur preparation et leur application en therapeutique
BE888417A (fr) Nouveaux derives de theophyllinylmethyldioxolane, leur procedes de preparation et leur application en therapeutique,
TR23491A (tr) Triazol veya mudazol gruplari ve tetrapidroforan ihtiva eden bilesimler,bunlarin fungasidler olarak kullanilmasi ve bunlarin hazirlanmasi icin usuller
FR2544309B1 (fr) Diphenylazomethines hydroxylees, leur preparation et leur application en therapeutique
BE891393A (fr) Esthers d'hydroxymethylpyrazines substituees leur preparation et leur utilisation therapeutique
FR2582302B2 (fr) Nouvelles (amino-1 ethylidenyl)-2 indanediones-1,3 substituees, leur methode de preparation et leur application therapeutique
IT8603587A0 (it) Cannula per aspirazione chirurgica
FR2523128B1 (fr) Nouveaux derives de la 1,4-dihydropyridine, leur preparation et medicaments contenant ces derives
FR2571722B1 (fr) Derives de benzimidazolone, leur preparation et leur application en therapeutique
DK38986D0 (da) Medicinsk inhalationsapparat
FR2547582B1 (fr) 3-aminomethyl-5-methyl-1,4 dioxannes substitues, leur preparation et leur application en therapeutique
FR2589156B3 (fr) Acides 4-(3-thienyl)-phenyl-alcanoiques, leur preparation et medicaments les contenant
FR2548182B1 (fr) Nouveaux derives du (carbalkoxy-2 (pyrrolylcarboxamido)-4 phenoxy)-1 amino-3 propanol-2, leur preparation et leur utilisation en therapeutique
FR2548667B1 (fr) Derives de benz-indolo-naphtyridine, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
ST Notification of lapse